MAPT and Alzheimer disease: A recent study has strongly suggested that tau protein is also an early indicator of preclinical AD, that aggregations of tau protein seem to precede the deposition of Aβ by approximately a decade, and that the location of pathogenic tau, but not Aβ, can predict the degeneration of the brain areas in the following 2 years (La Joie et al., 2020).